Massive 14,000-Patient review aims to map China's breast cancer treatment landscape
NCT ID NCT07476170
Summary
This study will analyze the medical records of 14,000 Chinese patients with advanced HR+/HER2- breast cancer to understand how they are treated in real-world hospitals. Researchers will look at which drugs are used first, how long treatments last, and what side effects occur, without giving any new treatments to patients. The goal is to gather knowledge about current treatment patterns and outcomes to help improve future care.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HR+/HER2- ADVANCED OR METASTATIC BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Conditions
Explore the condition pages connected to this study.